Publications by authors named "Jean-Marc Barret"

Claim this Profile
T
The Expression of Anti-Müllerian Hormone Type II Receptor (AMHRII) in Non-Gynecological Solid Tumors Offers Potential for Broad Therapeutic Intervention in Cancer.
Jean-Marc Barret, André Nicolas, Anne Jarry, Olivier Dubreuil, Didier Meseure

Biology (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell Activation.
Mélissa Prat, Marie Salon, Thibault Allain, Olivier Dubreuil, Grégory Noël, Jean-Marc Barret

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating CD14 CD16 intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression.
Mélissa Prat, Augustin Le Naour, Kimberley Coulson, Fanny Lemée, Hélène Leray, Jean-Marc Barret

J Immunother Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells.
Christophe Le Clorennec, Yassamine Lazrek, Olivier Dubreuil, Carla Sampaio, Christel Larbouret, Jean-Marc Barret

Cell Commun Signal· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophages.
Houcine Bougherara, Fariba Némati, André Nicolas, Gérald Massonnet, Martine Pugnière, Jean-Marc Barret

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3.
Christophe Le Clorennec, Hervé Bazin, Olivier Dubreuil, Christel Larbouret, Charline Ogier, Jean-Marc Barret

Mol Cancer Ther· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells.
Pauline Estupina, Alexandre Fontayne, Jean-Marc Barret, Nathalie Kersual, Olivier Dubreuil

Oncotarget· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrated Drosophila model system reveals unique properties for F14512, a novel polyamine-containing anticancer drug that targets topoisomerase II.
Sonia Chelouah, Caroline Monod-Wissler, Christian Bailly, Jean-Marc Barret, Nicolas Guilbaud

PLoS One· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system.
Anna Kruczynski, Isabelle Vandenberghe, Arnaud Pillon, Sabrina Pesnel, Liliane Goetsch, Jean-Marc Barret

Invest New Drugs· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triptolide is an inhibitor of RNA polymerase I and II-dependent transcription leading predominantly to down-regulation of short-lived mRNA.
Stéphane Vispé, Luc DeVries, Laurent Créancier, Jérome Besse, Sophie Bréand, Jean-Marc Barret

Mol Cancer Ther· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of pyridoisoquinoline derivatives F91873 and F91874, novel multikinase inhibitors with activity against the anaplastic lymphoma kinase.
Anna Kruczynski, Patrice Mayer, Arnaud Marchand, Stéphane Vispé, Emmanuel Fournier, Jean-Marc Barret

Anticancer Drugs· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of conjugated spermine derivatives with 7-nitrobenzoxadiazole (NBD), rhodamine and bodipy as new fluorescent probes for the polyamine transport system.
Yves Guminski, Martial Grousseaud, Sandrine Cugnasse, Viviane Brel, Jean-Philippe Annereau, Jean-Marc Barret

Bioorg Med Chem Lett· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.
Jean-Marc Barret, Anna Kruczynski, Stéphane Vispé, Jean-Philippe Annereau, Viviane Brel

Cancer Res· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis.
Isabelle Vandenberghe, Laurent Créancier, Stéphane Vispé, Jean-Philippe Annereau, Jean-Marc Barret

Biochem Pharmacol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of vinflunine: effector pathways and potential for synergies.
Diane Braguer, Jean-Marc Barret, Hayley McDaid, Anna Kruczynski

Semin Oncol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential mechanisms of resistance to microtubule inhibitors.
Maria Kavallaris, Jean-Philippe Annereau, Jean-Marc Barret

Semin Oncol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of bengacarboline derivatives.
Annie Pouilhès, Cyrille Kouklovsky, Yves Langlois, Jean-Pierre Baltaze, Stéphane Vispé, Jean-Marc Barret

Bioorg Med Chem Lett· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of 9-acridinyl sulfur derivatives: sulfides, sulfoxides and sulfones. Comparison of their activity on tumour cells.
Christiane Santelli-Rouvier, Jean-Marc Barret, Christopher M Farrell, Derek Sharples, Bridget T Hill

Eur J Med Chem· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor pharmacology -- quo vadis?
Christian Bailly, Jean-Marc Barret, Anna Kruczynski

Curr Med Chem Anticancer Agents· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased nucleotide excision repair activity and alterations of topoisomerase IIalpha are associated with the in vivo resistance of a P388 leukemia subline to F11782, a novel catalytic inhibitor of topoisomerases I and II.
Anna Kruczynski, Jean-Marc Barret, Benoît Van Hille, Nathalie Chansard, Jackie Astruc

Clin Cancer Res· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apoptotic cell death induction by F 11782 a novel dual catalytic inhibitor of topoisomerases I and II.
Chantal Etiévant, Anna Kruczynski, Jean-Marc Barret, Dominique Perrin, Bridget T Hill

Biochem Pharmacol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential binding to the alpha/beta-tubulin dimer of vinorelbine and vinflunine revealed by nuclear magnetic resonance analyses.
Christine Fabre, Jerzy Czaplicki, Michel Wright, Bridget Hill, Jean Marc Barret

Biochem Pharmacol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F 11782, a novel catalytic inhibitor of topoisomerases I and II, induces atypical, yet cytotoxic DNA double-strand breaks in CHO-K1 cells.
Jean-Marc Barret, Chantal Etiévant, Caroline Baudouin, Kirsten Skov, Marie Charvéron

Anticancer Res· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents.
Jean-Marc Barret, Anna Kruczynski, Chantal Etiévant, Bridget T Hill

Cancer Chemother Pharmacol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel aspects of natural and modified vinca alkaloids.
Alain Duflos, Anna Kruczynski, Jean-Marc Barret

Curr Med Chem Anticancer Agents· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis